As of 2025-07-15, the Fair Value of Evoke Pharma Inc (EVOK) is -37.58 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.13 USD, the upside of Evoke Pharma Inc is -832.62%.
With the market price of 5.13 USD and our fair value calculation, Evoke Pharma Inc (EVOK) is not a good investment. Investing in EVOK stocks now will result in a potential loss of 832.62%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -13.15 | -8.54 | -8.22 | -7.79 | -5.35 | -8.61 |
| YoY growth | -84.43% | 35.06% | 3.75% | 5.20% | 31.31% | -1.82% |
| Market Cap (mil) | 3.47 |
| P/E | |
| Forward P/E |
| EPS | -7.52 |
| Avg earnings growth rate | -1.82% |
| TTM earnings | -5.08 |